Laman UtamaUTHR • NASDAQ
add
United Therapeutics Corp
Tutup sebelumnya
$437.33
Julat hari
$432.53 - $446.08
Julat tahun
$266.98 - $479.50
Permodalan pasaran
19.16B USD
Bilangan Purata
713.84K
Nisbah P/E
16.85
Hasil dividen
-
Pertukaran utama
NASDAQ
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Sep 2025info | Perubahan T/T |
|---|---|---|
Hasil | 799.50J | 6.76% |
Perbelanjaan pengendalian | 309.30J | 20.07% |
Pendapatan bersih | 338.70J | 9.58% |
Margin untung bersih | 42.36 | 2.64% |
Pendapatan bagi setiap syer | 7.16 | 1.25% |
EBITDA | 411.20J | -3.77% |
Kadar cukai berkesan | 22.67% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Sep 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 2.77B | -16.80% |
Jumlah aset | 7.35B | 3.20% |
Jumlah liabiliti | 760.90J | -25.56% |
Jumlah ekuiti | 6.59B | — |
Syer tertunggak | 43.06J | — |
Harga kepada buku | 2.85 | — |
Pulangan pada aset | 12.76% | — |
Pulangan pada modal | 14.14% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Sep 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 338.70J | 9.58% |
Tunai daripada operasi | 562.10J | 49.02% |
Tunai daripada pelaburan | 140.90J | 222.63% |
Tunai daripada pembiayaan | -956.00J | -1,391.42% |
Perubahan bersih dalam tunai | -253.00J | -227.65% |
Aliran tunai bebas | 157.44J | -36.60% |
Perihal
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire. Wikipedia
Diasaskan
1996
Ibu pejabat
Tapak web
Pekerja
1,305
